|
Author: Pleunie Rood, Rita Bottino, A. Balamurugan, Yong Fan, David Cooper, Massimo Trucco
Keywords: adult stem cells,autoimmunity,beta cell regeneration,islet transplantation,type 1 diabetes
Summary: Diabetes clinical onset, i.e., establishment of a detectable, chronic hyperglycemia, occurs at a
diabetes. Type 1 diabetes (T1D) is an autoimmune disease in
Pharmaceutical Research; Vol. 23 Number 2, Feb 2006;Published Date:01/31/2006; DOI: 10.1007/s11095-005-9095-6
|
|
Author: Rajesh Krishna, Gary Herman, John Wagner
Keywords: disease progression,distal biomarkers,DPP4,glucose,proximal biomarkers,sitagliptin,type 2 diabetes
Summary: type 2 diabetes, wherein elucidation of target engagement and disease-related biomarkers significant type 2 diabetes. sitagliptin type 2 diabetes development program, plasma
The AAPS Journal; Vol. 10 Number 2, Jun 2008;Published Date:05/31/2008; DOI: 10.1208/s12248-008-9041-8
|
|
Author: Barry Hudson, Ann Schmidt
Keywords: advanced glycation end products,diabetes,immunoglobulin receptor,nephropathy,polymorphism,restenosis,vascular disease
Summary: advanced glycation end products; diabetes; immunoglobulin receptor; nephropathy; of hyperglycemia seen in diabetes and in inflammatory/pro- Common to all types of diabetes are specific complica-
Pharmaceutical Research; Vol. 21 Number 7, Jul 2004;Published Date:06/30/2004; DOI: 10.1023/B:PHAM.0000032992.75423.9b
|
|
Author: Joo Lee, Myung Lee
Keywords: diabetes mellitus,hepatic and intestinal CYP3A1/2,pharmacokinetics,rats,telithromycin
Summary: the expression and/or mRNA level of hepatic CYP3A1/2 increase in rat model of diabetes mellitus
diabetes mellitus compared with those in the control rats were evaluated. diabetes and their respective control rats.
Pharmaceutical Research; Vol. 25 Number 8, Aug 2008;Published Date:07/31/2008; DOI: 10.1007/s11095-008-9610-7
|
|
Author: Lina Nordquist, Niclas Roxhed, Patrick Griss, Göran Stemme
Keywords: diabetes,insulin lispro,intradermal,microneedles,rats,transdermal
Summary: Diabetes was induced by an intravenous injection of streptozotocin (50 mg/kg
diabetes; insulin lispro; intradermal; microneedles; rats; transdermal. With the discovery of insulin diabetes management was
Pharmaceutical Research; Vol. 24 Number 7, Jul 2007;Published Date:06/30/2007; DOI: 10.1007/s11095-007-9256-x
|
|
Author: Narayan Cheruvu, Aniruddha Amrite, Uday Kompella
Keywords: blood-retinal-barrier,diabetes,periocular injection,pigmentation,transscleral
Summary: To investigate the effects of diabetes on transscleral retinal delivery of celecoxib in albino and
h of fasting and diabetes was
Two months after diabetes induction, the integrity of blood-retinal-
Pharmaceutical Research; Vol. 26 Number 2, Feb 2009;Published Date:01/31/2009; DOI: 10.1007/s11095-008-9757-2
|
|
Author: Suna Choi, Miroslav Baudys, Sung Kim
Keywords: biodegradable,drug-delivery,glucagon-like peptide-1,hydrogel,type 2 diabetes
Summary: GLP-1 in diabetes treatment. promising candidate for treatment of type 2 diabetes mellitus. 1; hydrogel; type 2 diabetes.
Pharmaceutical Research; Vol. 21 Number 5, May 2004;Published Date:04/30/2004; DOI: 10.1023/B:PHAM.0000026435.27086.94
|
|
Author: Lillian Huang, Stephen Edwards, Maree Smith
Keywords: diabetes,metabolism,oxycodone,pharmacokinetics,rat
Summary: streptozotocin-induced diabetes on the pharmacokinetics of oxycodone and its metabolites, noroxyco- predominated over diabetes status. diabetes; metabolism; oxycodone; pharmacokinetics; rat.
Pharmaceutical Research; Vol. 22 Number 9, Sep 2005;Published Date:08/31/2005; DOI: 10.1007/s11095-005-6154-y
|